Carol O’Neill

530 total citations
16 papers, 387 citations indexed

About

Carol O’Neill is a scholar working on Psychiatry and Mental health, Pharmacology and Physiology. According to data from OpenAlex, Carol O’Neill has authored 16 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Psychiatry and Mental health, 4 papers in Pharmacology and 4 papers in Physiology. Recurrent topics in Carol O’Neill's work include Migraine and Headache Studies (4 papers), Sympathectomy and Hyperhidrosis Treatments (4 papers) and Cannabis and Cannabinoid Research (3 papers). Carol O’Neill is often cited by papers focused on Migraine and Headache Studies (4 papers), Sympathectomy and Hyperhidrosis Treatments (4 papers) and Cannabis and Cannabinoid Research (3 papers). Carol O’Neill collaborates with scholars based in United States, Australia and United Kingdom. Carol O’Neill's co-authors include Terri Sebree, Stan L. Banks, John J. Merrick, Tony L. Yaksh, Steven J. Siegel, Mark Pierce, William W. O’Neill, Harish Chandra, James A. Goldstein and Marcel O. Bonn‐Miller and has published in prestigious journals such as Journal of the American College of Cardiology, Journal of the American Academy of Child & Adolescent Psychiatry and The American Journal of Cardiology.

In The Last Decade

Carol O’Neill

15 papers receiving 365 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carol O’Neill United States 8 129 87 78 63 60 16 387
Jin Cui China 10 61 0.5× 76 0.9× 32 0.4× 17 0.3× 54 0.9× 45 423
Alise Kalteniece United Kingdom 19 43 0.3× 73 0.8× 29 0.4× 15 0.2× 260 4.3× 38 823
Charles P. Mercado United States 9 36 0.3× 53 0.6× 39 0.5× 36 0.6× 61 1.0× 10 436
M Umino Japan 13 24 0.2× 38 0.4× 11 0.1× 11 0.2× 66 1.1× 33 368
Yan‐Mei Guo China 9 26 0.2× 27 0.3× 16 0.2× 44 0.7× 82 1.4× 16 467
F. M. Perkins United States 10 29 0.2× 40 0.5× 56 0.7× 29 0.5× 33 0.6× 11 582
Michael Harned United States 11 139 1.1× 32 0.4× 15 0.2× 79 1.3× 66 1.1× 21 475
Norbert I.A. Overweg United States 8 45 0.3× 34 0.4× 18 0.2× 14 0.2× 77 1.3× 13 297
Asieh Naderi Iran 11 22 0.2× 11 0.1× 28 0.4× 35 0.6× 77 1.3× 25 393
Dry J France 11 132 1.0× 11 0.1× 99 1.3× 52 0.8× 162 2.7× 101 514

Countries citing papers authored by Carol O’Neill

Since Specialization
Citations

This map shows the geographic impact of Carol O’Neill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol O’Neill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol O’Neill more than expected).

Fields of papers citing papers by Carol O’Neill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol O’Neill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol O’Neill. The network helps show where Carol O’Neill may publish in the future.

Co-authorship network of co-authors of Carol O’Neill

This figure shows the co-authorship network connecting the top 25 collaborators of Carol O’Neill. A scholar is included among the top collaborators of Carol O’Neill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol O’Neill. Carol O’Neill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Palumbo, Joseph, et al.. (2021). LONGER-TERM TOLERABILITY AND EFFICACY OF ZYN002 CANNABIDIOL TRANSDERMAL GEL IN CHILDREN AND ADOLESCENTS WITH AUTISM SPECTRUM DISORDER: AN OPEN-LABEL PHASE 2 STUDY (BRIGHT [ZYN2-CL-030]). Journal of the American Academy of Child & Adolescent Psychiatry. 60(10). S258–S258. 1 indexed citations
2.
Heussler, Helen, et al.. (2020). [BRIGHT (ZYN2-CL-030)] TOLERABILITY AND EFFICACY OF ZYN002 CANNABIDIOL TRANSDERMAL GEL IN CHILDREN AND ADOLESCENTS WITH AUTISM SPECTRUM DISORDER: AN OPEN-LABEL PHASE 2 STUDY. Journal of the American Academy of Child & Adolescent Psychiatry. 59(10). S264–S265.
3.
Heussler, Helen, Jonathan Cohen, Natalie Silove, et al.. (2019). A phase 1/2, open-label assessment of the safety, tolerability, and efficacy of transdermal cannabidiol (ZYN002) for the treatment of pediatric fragile X syndrome. Journal of Neurodevelopmental Disorders. 11(1). 16–16. 74 indexed citations
4.
Merrick, John J., et al.. (2016). Identification of Psychoactive Degradants of Cannabidiol in Simulated Gastric and Physiological Fluid. Cannabis and Cannabinoid Research. 1(1). 102–112. 83 indexed citations
5.
Meadows, Kappa P., et al.. (2014). Sumatriptan Transdermal System Can Be Correctly Assembled and Applied During Migraine Attacks. Headache The Journal of Head and Face Pain. 54(5). 850–860. 6 indexed citations
6.
Pierce, Mark, et al.. (2013). Sumatriptan Iontophoretic Transdermal System: History, Study Results, and Use in Clinical Practice. Headache The Journal of Head and Face Pain. 53(S2). 34–42. 9 indexed citations
7.
8.
9.
Pierce, Mark, Thomas Marbury, Carol O’Neill, et al.. (2009). Zelrix™: A Novel Transdermal Formulation of Sumatriptan. Headache The Journal of Head and Face Pain. 49(6). 817–825. 49 indexed citations
10.
Siegel, Steven J., et al.. (2007). A Unique Iontophoretic Patch for Optimal Transdermal Delivery of Sumatriptan. Pharmaceutical Research. 24(10). 1919–1926. 37 indexed citations
11.
Chandra, Harish, James A. Goldstein, Carol O’Neill, et al.. (2004). Adverse outcome in aortic sclerosis is associated with coronary artery disease and inflammation. Journal of the American College of Cardiology. 43(2). 169–175. 86 indexed citations
12.
Swierzewski, Mark J., et al.. (2004). Early Response Time in Sexual Activity and Mood Following Testosterone Gel Replacement in Hypogonadal Males from the Testim(R) START Study.. PubMed. 6 Suppl 6. S16–21. 11 indexed citations
13.
Chandra, Harish, Cindy L. Grines, Carol O’Neill, et al.. (2002). Elevated C-reactive protein in diabetics with acute coronary syndrome: culprit or innocent bystander?. Journal of the American College of Cardiology. 39. 333–333. 1 indexed citations
14.
Chandra, Harish, et al.. (2001). Chlamydia pneumoniae exposure and inflammatory markers in acute coronary syndrome (CIMACS). The American Journal of Cardiology. 88(3). 214–218. 19 indexed citations
15.
Elwood, Robert W., et al.. (1990). Protecting pups in tests for infanticidal responsiveness in mice, Mus domesticus. Animal Behaviour. 40(4). 778–780. 6 indexed citations
16.
Hervig, R. L., J. S. Delaney, & Carol O’Neill. (1986). Evidence for Partial Remelting of Stannern and Comparison with a Silica-Bearing Clast in Juvinas. Metic. 21. 395. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jin Cui Breakdown of academic impact, for papers by Alise Kalteniece Breakdown of academic impact, for papers by Charles P. Mercado Breakdown of academic impact, for papers by M Umino Breakdown of academic impact, for papers by Yan‐Mei Guo Breakdown of academic impact, for papers by F. M. Perkins Breakdown of academic impact, for papers by Michael Harned Breakdown of academic impact, for papers by Norbert I.A. Overweg Breakdown of academic impact, for papers by Asieh Naderi Breakdown of academic impact, for papers by Dry J
Rankless by CCL
2026